Market closed

Kezar Life Sciences/$KZR

14:30
16:10
17:45
19:25
21:00
1D1W1MYTD1Y5YMAX

About Kezar Life Sciences

Kezar Life Sciences Inc is a clinical-stage biotechnology company. It is engaged in discovering and developing novel small molecule therapeutics to treat unmet needs in autoimmunity and cancer. The pipeline consist of product candidates such as Zetomipzomib (KZR-616), and KZR-261.

Ticker

$KZR
Sector
Health Care
Trading on
NASDAQ

Industry

Biotechnology
Headquarters
South San Francisco, United States

Employees

58
Website
www.kezarlifesciences.com

KZR Metrics

BasicAdvanced
$45M
-
-$13.15
0.22
-

$45M

0.22

$7.47

$6.16

55K

7.655

7.317

7.168

12.616

-59.86%

-29.02%

-54.72%

0.34

0.34

-0.592

-100.00%

8.50%

9.51%

KZR News

AllArticlesVideos
Glancy Prongay & Murray LLP Announces Investigation of Kezar Life Sciences, Inc. (KZR)

Glancy Prongay & Murray LLP Announces Investigation of Kezar Life Sciences, Inc. (KZR)

Business Wire·2 months ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.

Buy $KZR

$

Sign up or log in to buy
Capital at risk
Market closed

Upcoming events

No upcoming events

FAQs

What’s the current market cap for Kezar Life Sciences stock?

Kezar Life Sciences (KZR) has a market cap of $45M as of January 15, 2025.

What is the P/E ratio for Kezar Life Sciences stock?

The price to earnings (P/E) ratio for Kezar Life Sciences (KZR) stock is 0 as of January 15, 2025.

Does Kezar Life Sciences stock pay dividends?

No, Kezar Life Sciences (KZR) stock does not pay dividends to its shareholders as of January 15, 2025.

When is the next Kezar Life Sciences dividend payment date?

Kezar Life Sciences (KZR) stock does not pay dividends to its shareholders.

What is the beta indicator for Kezar Life Sciences?

Kezar Life Sciences (KZR) has a beta rating of 0.22. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.